Bristol Myers Squibb (NYSE: BMY)
Bristol Myers Squibb Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Bristol Myers Squibb Company Info
Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.
News & Analysis
2 No-Brainer Dividend Stocks You Can Buy With $100 in June
This pair of high-yield dividend payers offer yields near 6% and a chance for steady payout raises in the years to come.
This Unpopular Dividend Stock Is a Buy
This top pharma stock has fallen too far.
1 Stock I Wouldn't Touch With a 10-Foot Pole
This stock isn't as safe as it seems, and now isn't the time to dabble.
These Are Billionaires’ Favorite Healthcare Stocks
The Motley Fool analyzed 16 billionaire-led hedge funds to get an idea of their healthcare sector investment strategies.
Is Bristol Myers' Dividend in Danger?
Should investors brace for a dividend cut?
2 Beaten-Down Stocks to Buy and Hold for 10 Years
They offer plenty of upside and solid dividend growth.
Could Investing $100,000 in Bristol Myers Squibb Stock Make You a Millionaire?
Keep your goals in check when considering an extreme contrarian trade with Bristol Myers Squibb stock.
If You'd Invested $1,000 in Bristol Myers Squibb 5 Years Ago, Here's How Much You'd Have Today
The answer isn't great, but there's still reason to like Bristol Myers Squibb.
Valuation
Podcast Episodes
The Top Biotech Stocks to Watch Following ASH 2019
The potential to reshape treatment of blood cancer and disorders could mean big bucks for these companies.
3 Biggest Stories at the J.P. Morgan Healthcare Conference This Year
These stocks skyrocketed following exciting announcements.
Carl Icahn Takes Aim at Bristol-Myers Squibb
Carl Icahn's reportedly focusing his brand of investor activism on Bristol-Myers Squibb, but it's anyone's guess if he'll be able to convince the company to sell. Also, Celgene delivers a phase 3 win with blockbuster implications.
Heart-Thumping, Game-Changing Ways We're Treating Cardiovascular Disease
In this Valentine's Day edition, Industry Focus explores cholesterol busters, heart surgery, and the latest in anticoagulants.
Earnings Transcripts
Bristol Myers Squibb (BMY) Q1 2024 Earnings Call Transcript
BMY earnings call for the period ending March 31, 2024.
Bristol Myers Squibb (BMY) Q4 2023 Earnings Call Transcript
BMY earnings call for the period ending December 31, 2023.
Bristol Myers Squibb (BMY) Q3 2023 Earnings Call Transcript
BMY earnings call for the period ending September 30, 2023.
Bristol Myers Squibb (BMY) Q2 2023 Earnings Call Transcript
BMY earnings call for the period ending June 30, 2023.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.